GobyMeds GLP-1 Program Options: What's Available for Eligible Patients GobyMeds lists the following programs among its offerings for eligible patients: Compounded Semaglutide - a compounded GLP-1 receptor agonist program for weight management, starting at $99/month Compounded Tirzepatide - a compounded dual GIP/GLP-1 receptor agonist program, starting at $133/month NAD+ - cellular energy and metabolic support, starting at $116/month Sermorelin - peptide therapy designed to support natural growth hormone release, starting at $199/month Brand-name medications - GobyMeds lists Wegovy, Zepbound, Mounjaro, and Ozempic as available for eligible patients with limited supply Semaglutide is commonly discussed as a GLP-1 receptor agonist
For more detail, see our guide on GLP-1 medications and hair loss
Tirzepatide is a dual GLP-1/GIP agonist that helps in controlling glucose and obesity management
By mimicking the action of GLP-1, semaglutide influences multiple physiological processes to reduce appetite, increase feelings of fullness, and promote weight loss
Studies show that even small temperature variations can affect how these medications function in the body
How do you learn a drug name